Controlled Substances - As introduced, prohibits a healthcare facility from authorizing a licensed healthcare professional from performing a drug or alcohol test or screen on a patient who is pregnant, less than one year postpartum, or a newborn without written and oral consent; allows for a drug or alcohol test or screen to be performed without the consent of the patient in certain listed situations. - Amends TCA Title 33; Title 63 and Title 68.

HB 1102 requires healthcare facilities in Tennessee to obtain specific written and oral consent before performing drug or alcohol tests on pregnant patients, patients less than one year postpartum, or newborns. The consent must explain legal consequences, medical purpose, confidentiality, and be provided without coercion. Exceptions allow testing without consent only in medical emergencies where delaying treatment would endanger the patient or newborn. The bill also prohibits healthcare providers from refusing care due to a patient's refusal to test and ensures privacy protections extend to this patient group. It takes effect July 1, 2025.